CHYMOWIN BR TABLET is a combination of Bromelain, Rutoside and Trypsin which belongs to the group of medicines called Proteolytic Enzymes and Flavonoids respectively. It is used in the treatment of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, gout, joint issues related to inflammation, pain and swelling of joints, swelling associated with surgical wounds, pulmonary edema, ulcerative colitis, sports and accidental injuries, muscular cramps and spasms, tendinitis, bursitis, dental extraction, sinusitis, bronchitis and rhinitis.
Prior to starting the treatment with CHYMOWIN BR TABLET, your doctor might want you to take several diagnostic tests to understand your existing condition and to safely use this medicine to prevent the risk of any unusual effects.
CHYMOWIN BR TABLET is not recommended for use in patients with hemophilia (disorder in which blood doesn't clot normally), liver or kidney disorders and patients undergoing hemodialysis. CHYMOWIN BR TABLET should be taken with caution in patients with any bleeding disorders and heart disease.
CHYMOWIN BR TABLET is not recommended for use in pregnant and breastfeeding women. There is no data on the use of CHYMOWIN BR TABLET in children or elderly patients hence, always consult your doctor for advice before taking this medicine.
The most common side effects of taking CHYMOWIN BR TABLET are nausea, diarrhea, stomach upset, tiredness, dry mouth and skin rash. Consult your doctor if any of the side effects worsen.